SKYSTAR Trademark

Trademark Overview

On Monday, September 17, 2018, a trademark application was filed for SKYSTAR with the United States Patent and Trademark Office. The USPTO has given the SKYSTAR trademark a serial number of 88119367. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 9, 2022. This trademark is owned by Skyhawk Therapeutics, Inc.. The SKYSTAR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals, namely, small molecule therapeutic preparations for the correction of RNA expression, used in the treatment of cancers, neurological diseases, and other diseases
skystar

General Information

Serial Number88119367
Word MarkSKYSTAR
Filing DateMonday, September 17, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 9, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 5, 2019

Trademark Statements

Goods and ServicesPharmaceuticals, namely, small molecule therapeutic preparations for the correction of RNA expression, used in the treatment of cancers, neurological diseases, and other diseases
Pseudo MarkSKY STAR

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, September 22, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSkyhawk Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWaltham, MA 02451
Party NameSkyhawk Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Monday, May 9, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, May 9, 2022ABANDONMENT - NO USE STATEMENT FILED
Wednesday, September 15, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 14, 2021SOU EXTENSION 5 GRANTED
Thursday, September 9, 2021SOU EXTENSION 5 FILED
Thursday, September 9, 2021SOU TEAS EXTENSION RECEIVED
Saturday, March 20, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 18, 2021SOU EXTENSION 4 GRANTED
Thursday, March 18, 2021SOU EXTENSION 4 FILED
Thursday, March 18, 2021SOU TEAS EXTENSION RECEIVED
Friday, August 7, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 5, 2020SOU EXTENSION 3 GRANTED
Wednesday, August 5, 2020SOU EXTENSION 3 FILED
Wednesday, August 5, 2020SOU TEAS EXTENSION RECEIVED
Saturday, March 21, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 19, 2020SOU EXTENSION 2 GRANTED
Thursday, March 19, 2020SOU EXTENSION 2 FILED
Thursday, March 19, 2020SOU TEAS EXTENSION RECEIVED
Wednesday, October 23, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 23, 2019CORRECTED NOA E-MAILED
Tuesday, October 22, 2019DIVISIONAL PROCESSING COMPLETE
Wednesday, October 2, 2019DIVISIONAL REQUEST RECEIVED
Tuesday, October 22, 2019SOU EXTENSION 1 GRANTED
Wednesday, October 2, 2019SOU EXTENSION 1 FILED
Monday, October 21, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, October 2, 2019TEAS REQUEST TO DIVIDE RECEIVED
Wednesday, October 2, 2019SOU TEAS EXTENSION RECEIVED
Tuesday, April 2, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 5, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 5, 2019PUBLISHED FOR OPPOSITION
Wednesday, January 16, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, December 28, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 28, 2018ASSIGNED TO EXAMINER
Saturday, September 22, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 20, 2018NEW APPLICATION ENTERED

Related Keywords

skystar diseases treatment used cancers neurological other expression correction small namely